ArticleCancers2022

Opportunities for Participation in Randomized Controlled Trials for Patients with Multiple Myeloma: Trial Access Depends on Restrictive Eligibility Criteria and Patient Expectations.

Amelie Boquoi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.